Fact CheckerSign in

NCT06333587Recruiting

Minimally Invasive Treatments of the Thyroid

Multicenter International Prospective Analysis on Minimally Invasive Treatments of the Thyroid (MIPA- MITT) of of Micropapillary Thyroid Carcinoma

Source: ClinicalTrials.gov · Last updated 27 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)

Status (registry)
Recruiting
Study type
Observational
Enrollment
270 (estimated)
First submitted
21 Mar 2024
Start date
10 Oct 2022
Primary completion date
31 Dec 2025
Lead sponsor
European Institute of Oncology
NCT number
NCT06333587

What you commit to

  • Study type: Observational
  • Planned participants: 270
  • From 10 Oct 2022 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Tumors \> 1 cm, other citological type, refusal of MITT, unsuitable for MITT, unmanageable coagulative disorders
  • Patients with psychiatric, addictive, or any disorder, which compromises ability to give informed consent for participation in this study

Who the study is looking for

  • Patients \> 18years
  • Patients with diagnosis of papillary thyroid microcarcinoma, citologically proven, suitable for MITT.
  • Written informed consent must be signed and dated by the patient and the investigator prior to inclusion.
  • Patients must be accessible for follow-up

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
European Institute of Oncology
Coordinator of this site? Confirm its status
MilanItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.